<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129017/" ref="ordinalpos=2339&amp;ncbi_uid=6489264&amp;link_uid=PMC4129017" image-link="/pmc/articles/PMC4129017/figure/fig03/" class="imagepopup">Figure 3.  From: miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K <span class="highlight" style="background-color:">pathway</span> and HoxA10. </a></div><br /><div class="p4l_captionBody">miR-218 regulated PTEN/AKT/PI3K pathway in HCC. (A) MHC97L cells were transfected with miR-218-mimics and miR-218-inhibitor, along with their corresponding control siRNAs. Western blotting analysis was used to examine the cell cycle proteins Cyclin D1 and p21, and (B) PTEN/AKT/PI3K signaling pathway related proteins, including AKT/phosphorylated-AKT, GSK-3β phosphorylated-GSK-3β PTEN.</div></div>